Global gene expression profiling and histochemical analysis of the developing human fetal pancreas.

PubWeight™: 1.21‹?› | Rank: Top 10%

🔗 View Article (PMID 18094957)

Published in Diabetologia on December 18, 2007

Authors

S A Sarkar1, S Kobberup, R Wong, A D Lopez, N Quayum, T Still, A Kutchma, J N Jensen, R Gianani, G M Beattie, J Jensen, A Hayek, J C Hutton

Author Affiliations

1: Barbara Davis Center for Childhood Diabetes, UCDHSC, 1775 N. Ursula Street, Mail Stop B-140, P.O. Box 6511, Aurora, CO 80045, USA.

Articles citing this

Targeting SOX17 in human embryonic stem cells creates unique strategies for isolating and analyzing developing endoderm. Cell Stem Cell (2011) 1.41

Endocrine cell clustering during human pancreas development. J Histochem Cytochem (2009) 1.26

Development of the human pancreas from foregut to endocrine commitment. Diabetes (2013) 1.21

The amniotic fluid transcriptome: a source of novel information about human fetal development. Obstet Gynecol (2012) 1.20

One process for pancreatic beta-cell coalescence into islets involves an epithelial-mesenchymal transition. J Endocrinol (2009) 1.16

Deconstructing pancreas development to reconstruct human islets from pluripotent stem cells. Cell Stem Cell (2010) 1.13

The physiological effects of deleting the mouse SLC30A8 gene encoding zinc transporter-8 are influenced by gender and genetic background. PLoS One (2012) 1.11

Consequences of a compromised intrauterine environment on islet function. J Endocrinol (2010) 1.04

Characterization of glucose-insulin responsiveness and impact of fetal number and sex difference on insulin response in the sheep fetus. Am J Physiol Endocrinol Metab (2011) 0.99

Generation of β cells from human pluripotent stem cells: are we there yet? Ann N Y Acad Sci (2014) 0.94

MicroRNA signature of the human developing pancreas. BMC Genomics (2010) 0.93

Initial cell seeding density influences pancreatic endocrine development during in vitro differentiation of human embryonic stem cells. PLoS One (2013) 0.92

The ontogeny of the endocrine pancreas in the fetal/newborn baboon. J Endocrinol (2012) 0.88

Islet formation in mice and men: lessons for the generation of functional insulin-producing β-cells from human pluripotent stem cells. Curr Opin Genet Dev (2015) 0.86

The window period of NEUROGENIN3 during human gestation. Islets (2014) 0.81

Neurogenin 3 Expressing Cells in the Human Exocrine Pancreas Have the Capacity for Endocrine Cell Fate. PLoS One (2015) 0.81

Overexpression of PAX4 reduces glucagon expression in differentiating hESCs. Islets (2014) 0.81

Prospectively isolated NGN3-expressing progenitors from human embryonic stem cells give rise to pancreatic endocrine cells. Stem Cells Transl Med (2014) 0.80

The Role of ARX in Human Pancreatic Endocrine Specification. PLoS One (2015) 0.79

A CRM1-mediated nuclear export signal is essential for cytoplasmic localization of neurogenin 3 in neurons. PLoS One (2013) 0.79

Pancreas development in humans. Curr Opin Endocrinol Diabetes Obes (2014) 0.79

The CD34 surface antigen is restricted to glucagon-expressing cells in the early developing bovine pancreas. Histochem Cell Biol (2011) 0.78

Lymphangiogenesis and angiogenesis during human fetal pancreas development. Vasc Cell (2014) 0.77

Paradigm of Time-sequence Development of the Intestine of Suckling Piglets with Microarray. Asian-Australas J Anim Sci (2012) 0.75

Derivation of insulin-producing beta-cells from human pluripotent stem cells. Rev Diabet Stud (2014) 0.75

Neurogenin 3 is regulated by neurotrophic tyrosine kinase receptor type 2 (TRKB) signaling in the adult human exocrine pancreas. Cell Commun Signal (2016) 0.75

Ex vivo Expansion of Human Adult Pancreatic Cells with Properties of Distributed Stem Cells by Suppression of Asymmetric Cell Kinetics. J Stem Cell Res Ther (2013) 0.75

Pancreatic Beta Cell Identity in Humans and the Role of Type 2 Diabetes. Front Cell Dev Biol (2017) 0.75

Articles by these authors

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet (1997) 44.03

Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet (1997) 29.18

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet (1997) 25.40

Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet (1992) 25.28

Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum. Immunochemistry (1966) 15.12

Evidence-based health policy--lessons from the Global Burden of Disease Study. Science (1996) 13.50

Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med (1997) 8.25

Mortality from smoking worldwide. Br Med Bull (1996) 7.87

Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: global Burden of Disease Study. Lancet (1997) 7.29

The global burden of disease in 1990: summary results, sensitivity analysis and future directions. Bull World Health Organ (1994) 6.99

The global burden of disease, 1990-2020. Nat Med (1998) 6.50

Quantifying disability: data, methods and results. Bull World Health Organ (1994) 4.99

Measuring the accumulated hazards of smoking: global and regional estimates for 2000. Tob Control (2003) 4.94

Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. J Clin Oncol (2001) 4.89

Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet (1997) 4.77

Armed conflict as a public health problem. BMJ (2002) 4.42

Healthy life expectancy in 191 countries, 1999. Lancet (2001) 4.31

Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes (1996) 4.20

On the comparable quantification of health risks: lessons from the Global Burden of Disease Study. Epidemiology (1999) 3.66

Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group. N Engl J Med (1996) 3.63

The decline in child mortality: a reappraisal. Bull World Health Organ (2000) 3.46

Global and regional cause-of-death patterns in 1990. Bull World Health Organ (1994) 3.37

Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group. Arch Dermatol (1998) 3.26

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest (1999) 3.21

Progress and directions in refining the global burden of disease approach: a response to Williams. Health Econ (2000) 3.17

Changes in conserved region 2 of Escherichia coli sigma 70 affecting promoter recognition. J Mol Biol (1990) 3.04

Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc Natl Acad Sci U S A (2001) 3.04

The use of cause-of-death statistics for health situation assessment: national and international experiences. World Health Stat Q (1990) 2.84

Antiislet autoantibodies usually develop sequentially rather than simultaneously. J Clin Endocrinol Metab (1996) 2.78

Clinical characteristics of the Munchausen syndrome. A review and 3 new case histories. Psychother Psychosom (1989) 2.71

Brief report: specific executive function profiles in three neurodevelopmental disorders. J Autism Dev Disord (1999) 2.64

Mitochondrial DNA molecules and virtual number of mitochondria per cell in mammalian cells. J Cell Physiol (1988) 2.59

Proventriculotomy to relieve foreign body impaction in ostriches. J Am Vet Med Assoc (1991) 2.58

The utility of DALYs for public health policy and research: a reply. Bull World Health Organ (1997) 2.49

Anaphylatoxin in its relation to the complement system. Science (1967) 2.37

Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother Oncol (1998) 2.36

Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients. J Clin Invest (1998) 2.35

Nonspecific bronchial reactivity in occupational asthma. J Allergy Clin Immunol (1979) 2.22

Regional, disease specific patterns of smoking-attributable mortality in 2000. Tob Control (2004) 2.12

Transcription factor hepatocyte nuclear factor 6 regulates pancreatic endocrine cell differentiation and controls expression of the proendocrine gene ngn3. Mol Cell Biol (2000) 2.11

Intraorganellar calcium and pH control proinsulin cleavage in the pancreatic beta cell via two distinct site-specific endopeptidases. Nature (1988) 2.07

XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results. Br J Cancer (2011) 1.90

Insulin release: the fuel hypothesis. Metabolism (1979) 1.84

Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause. N Engl J Med (1985) 1.81

An immunodeficiency characterized by defective signal transduction in T lymphocytes. N Engl J Med (1989) 1.79

Prospective, randomized, endoscopic-blinded trial comparing precolonoscopy bowel cleansing methods. Dis Colon Rectum (1994) 1.76

Early introduction of solid foods among urban African-American participants in WIC. J Am Diet Assoc (1999) 1.73

Sunitinib therapy for metastatic renal cell carcinoma: recommendations for management of side effects. Can Urol Assoc J (2007) 1.72

Rat endocrine pancreatic development in relation to two homeobox gene products (Pdx-1 and Nkx 6.1). J Histochem Cytochem (1998) 1.71

Number of autoantibodies (against insulin, GAD or ICA512/IA2) rather than particular autoantibody specificities determines risk of type I diabetes. J Autoimmun (1996) 1.68

Low-molecular-weight constituents of isolated insulin-secretory granules. Bivalent cations, adenine nucleotides and inorganic phosphate. Biochem J (1983) 1.65

Effect of HER2 on prognosis and benefit from peri-operative chemotherapy in early oesophago-gastric adenocarcinoma in the MAGIC trial. Ann Oncol (2012) 1.65

Molecular cloning of phogrin, a protein-tyrosine phosphatase homologue localized to insulin secretory granule membranes. J Biol Chem (1996) 1.64

T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins. Nature (1990) 1.64

Effect of carbon dioxide in acute mountain sickness: a rediscovery. Lancet (1988) 1.64

Methods for the quantification of DNA double-strand breaks determined from the distribution of DNA fragment sizes measured by pulsed-field gel electrophoresis. Radiat Res (1995) 1.61

Complete structural determination of lipopolysaccharide obtained from deep rough mutant of Escherichia coli. Purification by high performance liquid chromatography and direct analysis by plasma desorption mass spectrometry. J Biol Chem (1988) 1.60

Importance of blood volume cultured in the detection of bacteremia. Eur J Clin Microbiol Infect Dis (1989) 1.59

The internal pH and membrane potential of the insulin-secretory granule. Biochem J (1982) 1.59

Measuring the burden of disease. Lancet (1998) 1.58

Household income and health care expenditures in Mexico. Health Policy (1997) 1.58

Reaction of systemic lupus erythematosus antinative DNA antibodies with native DNA fragments from 20 to 1,200 base pairs. J Clin Invest (1980) 1.57

Long-term results of total condylar knee arthroplasty in rheumatoid arthritis. J Bone Joint Surg Br (1992) 1.56

Late progression to diabetes and evidence for chronic beta-cell autoimmunity in identical twins of patients with type I diabetes. Diabetes (1995) 1.55

The epidemiology of shoulder dislocations. Arch Orthop Trauma Surg (1989) 1.53

Patients with advanced cancer: a survey of the understanding of their illness and expectations from palliative radiotherapy for symptomatic metastases. Clin Oncol (R Coll Radiol) (2001) 1.53

The stimulus-secretion coupling of glucose-induced insulin release. Effect of exogenous pyruvate on islet function. Biochem J (1978) 1.52

The stimulus-secretion coupling of glucose-induced insulin release. XXXV. The links between metabolic and cationic events. Diabetologia (1979) 1.52

Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes. Diabetes (1999) 1.52

B cell origin of non-T cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation. J Clin Invest (1984) 1.51

Current indications and results of VATS in the evaluation and management of hemodynamically stable thoracic injuries. Eur J Cardiothorac Surg (2004) 1.48

Cathepsin B-related proteases in the insulin secretory granule. J Biol Chem (1984) 1.47

Nicotinamide is a potent inducer of endocrine differentiation in cultured human fetal pancreatic cells. J Clin Invest (1993) 1.46

Measuring dependence in smokeless tobacco users. Addict Behav (1995) 1.46

At least one in seven cases of cancer is caused by smoking. Global estimates for 1985. Int J Cancer (1994) 1.45

Hypertension in developing countries. World Health Stat Q (1988) 1.45

ICA69 is expressed equally in the human endocrine and exocrine pancreas. Diabetologia (1996) 1.44

Death from metastatic donor-derived ovarian cancer in a male kidney transplant recipient. Am J Transplant (2009) 1.41

Infective crystalline keratopathy secondary to non-tuberculous mycobacterium (Mycobacterium abscessus) in a non-traumatized eye. Eye (Lond) (2007) 1.40

[Hip fractures]. Ugeskr Laeger (1997) 1.39

Diagnostic reliability of combined physical examination, mammography, and fine-needle puncture ("triple-test") in breast tumors. A prospective study. Cancer (1987) 1.39

Use of the Hickman-Crawford critical care catheter in marrow transplant recipients: a pulmonary artery catheter-adaptable central venous access. Crit Care Med (1994) 1.39

Molecular cloning of a pancreatic islet-specific glucose-6-phosphatase catalytic subunit-related protein. Diabetes (1999) 1.39

Improvement in transfusion safety using a specially designed transfusion wristband. Transfus Med (2000) 1.38

Translational regulation of proinsulin biosynthesis and proinsulin conversion in the pancreatic beta-cell. Semin Cell Dev Biol (2000) 1.38

Predictive power of screening for antibodies against insulinoma-associated protein 2 beta (IA-2beta) and zinc transporter-8 to select first-degree relatives of type 1 diabetic patients with risk of rapid progression to clinical onset of the disease: implications for prevention trials. Diabetologia (2009) 1.37

Automated HPLC screening of newborns for sickle cell anemia and other hemoglobinopathies. Clin Chem (1996) 1.37

Coronary disease in familial hypercholesterolemia. Circulation (1967) 1.36

The stimulus-secretion coupling of glucose-induced insulin release. Metabolic effects of menadione in isolated islets. Eur J Biochem (1978) 1.36

Isolation and characterisation of insulin secretory granules from a rat islet cell tumour. Diabetologia (1982) 1.36

Accurate characterization of image intensifier distortion. Med Phys (1992) 1.35

Sustained proliferation of PDX-1+ cells derived from human islets. Diabetes (1999) 1.35

WIC-based interventions to promote breastfeeding among African-American Women in Baltimore: effects on breastfeeding initiation and continuation. J Hum Lact (1998) 1.35

Identification of the type 2 proinsulin processing endopeptidase as PC2, a member of the eukaryote subtilisin family. J Biol Chem (1992) 1.34

The epidemiology of fractures of the proximal humerus. Arch Orthop Trauma Surg (1989) 1.34

Ex vivo expansion of human pancreatic endocrine cells. J Clin Endocrinol Metab (1997) 1.33

The insulin-secretory-granule carboxypeptidase H. Purification and demonstration of involvement in proinsulin processing. Biochem J (1987) 1.33